Onward Medical N.V., a medical technology company, develops and commercializes therapies to enable functional recovery for people with spinal cord injury (SCI) in the United States, Europe, and internationally. The company offers ARCEX System, an external stimulator that is intended to improve hand strength and sensation following SCI; ARCIM System, an implantable system currently used to explore potential indications in clinical feasibility studies; ARCBCI System, an implantable system currently being investigated to enable thought driven movement of the legs and upper extremities. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Frequently asked questions
What sector does ONWARD MEDICAL BV EO -12 (63E) operate in?
ONWARD MEDICAL BV EO -12 belongs to the Healthcare sector and operates in the Biotechnology industry.
What is ONWARD MEDICAL BV EO -12 (63E) current stock price?
As of the latest data, ONWARD MEDICAL BV EO -12 stock price is €2.67, with a previous close of €2.69. ONWARD MEDICAL BV EO -12 lost -€0.02 in the last trading session, representing a -0.74% loss.
What is ONWARD MEDICAL BV EO -12 (63E) current market capitalization?
ONWARD MEDICAL BV EO -12 market cap is approximately 185.29 million.
What is ONWARD MEDICAL BV EO -12 (63E) Earnings Per Share (EPS)?
The trailing EPS is -€0.85.
Does ONWARD MEDICAL BV EO -12 (63E) pay dividends?
No. ONWARD MEDICAL BV EO -12 does not pay a dividend.
When is ONWARD MEDICAL BV EO -12 (63E) next earnings report?
ONWARD MEDICAL BV EO -12 is expected to release its next earnings report on June 30, 2026.
What is ONWARD MEDICAL BV EO -12 (63E) beta (volatility) score?
ONWARD MEDICAL BV EO -12 has a beta of 0.854, meaning its volatility is roughly in line with the market.
